Skip to Content
ProceedingsProceedings
  • Extended Abstract
  • Open Access

7 August 2019

2 Pages

Novel Sortase A Inhibitors to Counteract Gram-Positive Bacterial Biofilms †

,
,
,
,
,
,
,
,
and
1
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, (STEBICEF), University of Palermo, via Archirafi 32, 90123 Palermo, Italy
2
Drug Sciences Department, Medicinal Chemistry and Pharmaceutical Technology Section, University of Pavia, via Taramelli 12, 27100 Pavia, Italy
3
APP Latvian Biomedical Research and Study Centre (BMC), Rātsupītes iela 1, LV-1067 Rīga, Latvia
*
Author to whom correspondence should be addressed.
Sortase A (SrtA) is a membrane enzyme responsible for the covalent anchoring of surface proteins on the cell wall of Gram-positive bacteria. Nowadays, it is considered an interesting target for the development of new anti-infective drugs which aim to interfere with important Gram-positive virulence mechanisms. Along the years, we studied the anti-staphylococcal and anti-biofilm activity of some natural and synthetic polyhalogenated pyrrolic compounds, called pyrrolomycins. Some of them were active on Gram-positive pathogens at a μg/mL range of concentration (1.5–0.045 μg/mL) and showed a biofilm inhibition in the range of 50–80% [1,2,3].
We designed and synthesized novel pyrrolomycins, applying an efficient and easy-to-use microwave synthetic methodology. All compounds showed a good inhibitory activity toward SrtA, in accordance with the molecular modelling studies, having IC50 values ranging from 130 to 300 µM comparable to berberine hydrochloride. The best compound exhibits a high capability to interfere with biofilm formation of S. aureus with an IC50 in the nanomolar range. It is also effective in altering S. aureus murein hydrolase activity, responsible for degradation, turnover, and maturation of bacterial peptidoglycan [4]. In light of these encouraging results, herein we present our efforts in finding new effective agents able to inhibit biofilm formation.

References

  1. Raimondi, M.V.; Cascioferro, S.; Schillaci, D.; Petruso, P. Synthesis and antimicrobial activity of new bromine-rich pyrrole derivatives related to monodeoxypyoluteorin. Eur. J. Med. Chem. 2006, 41, 1439–1445. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Raimondi, M.V.; Schillaci, D.; Petruso, S. Synthesis and anti-staphylococcal activity of new halogenated pyrroles related to Pyrrolomycins F. J. Heterocyclic Chem. 2007, 44, 1407–1411. [Google Scholar] [CrossRef] [Scilit]
  3. Schillaci, D.; Petruso, S.; Raimondi, M.V.; Cusimano, M.G.; Cascioferro, S.; Scalisi, M.; La Giglia, M.A.; Vitale, M. Pyrrolomycins as potential anti-staphylococcal biofilms agents. Biofouling 2010, 26, 433–438. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Raimondi, M.V.; Listro, R.; Cusimano, M.G.; La Franca, M.; Faddetta, T.; Gallo, G.; Schillaci, D.; Collina, S.; Leonchiks, A.; Barone, G. Pyrrolomycins as antimicrobial agents. Microwave-assisted organic synthesis and insights into their antimicrobial mechanism of action. Bioorg. Med. Chem. 2019, 27, 721–728. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.